//
Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up
How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD
Poor R-wave progression as a predictor of sudden cardiac death in general population and subjects with coronary artery disease
Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the JAHA Editors
2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk
Significantly less inappropriate shocks in ischemic patients compared to non-ischemic patients: The S-ICD experience of a high volume single-center
Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization
Position paper of the EACVI and EANM on artificial intelligence applications in multimodality cardiovascular imaging using SPECT/CT, PET/CT, and cardiac CT